SMTL ID : 6jvo.2 (1 other biounit)

Crystal structure of human MTH1 in complex with compound MI1022

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x CJ6: N4-cyclopropyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine(Non-covalent)

CJ6.1: 12 residues within 4Å: Chain A: Y.6, T.7, L.8, N.32, G.36, F.71, F.73, W.116, D.118, D.119, W.122, F.138 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.71, A:F.71, A:F.71, A:F.73, A:W.116, A:F.138 Hydrogen bonds: A:N.32, A:N.32, A:D.118 Salt bridges: A:D.118, A:D.119

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Peng, C. et al., Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity. Bioorg.Chem. (2021)

Release Date

2020-10-28

Peptides

7,8-dihydro-8-oxoguanine triphosphatase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

7,8-dihydro-8-oxoguanine triphosphatase

Related Entries With Identical Sequence